Murdoch Children's Research Institute, Parkville, Victoria 3052, Australia.
Research Unit on Gynaecology and Obstetrics, Institute of Clinical Research, University of Southern Denmark, 5000 Odense C, Denmark.
Int J Epidemiol. 2018 Apr 1;47(2):561-571. doi: 10.1093/ije/dyx272.
The early life microbiome contributes to immune development. Antibiotics during pregnancy alter the microbiome and may influence disease risks in the offspring. We investigated the relationship between maternal antibiotic exposure before and during pregnancy, and risk of childhood hospitalization with infection.
We used population-based Danish national databases for pregnancies between 1995 and 2009. Infants were followed from birth until their first infection-related hospitalization, death, 14th birthday, emigration or end-2009. Exposure was maternal antibiotics prescribed before and during pregnancy. Outcome was infection-related hospitalization.
141 359 (18%) mothers had at least one antibiotic prescription during pregnancy, 230 886 (29.4% of those with complete data) in the 18 months before pregnancy. Of 776 657 live-born singletons, 443 546 infection-related hospitalizations occurred in 222 524 (28.6%) children. Pregnancy antibiotic exposure was associated with increased risk of childhood infection-related hospitalization [hazard ratio (HR) 1.18, 95% confidence interval (CI) 1.17-1.19]. In mothers prescribed antibiotics only during pregnancy whose child did not receive pre-hospitalization antibiotics, this association was present only in those born vaginally. Higher risks of infection-related hospitalization occurred when pregnancy antibiotic prescriptions were closer to birth and in mothers receiving more pregnancy antibiotics. Children born to mothers exposed to antibiotics before (but not during) pregnancy also had increased risk of infection-related hospitalization (HR 1.10, 95% CI 1.07-1.12).
Antibiotic exposure before or during pregnancy was associated with increased risk of childhood hospitalized infections. Alteration of the maternally derived microbiome and shared heritable and environmental determinants are possible contributory mechanisms.
生命早期的微生物组有助于免疫发育。怀孕期间使用抗生素会改变微生物组,并可能影响后代的疾病风险。我们研究了母亲在怀孕前后使用抗生素与儿童感染住院风险之间的关系。
我们使用了 1995 年至 2009 年期间基于人群的丹麦国家数据库进行研究。从出生开始,对婴儿进行随访,直到他们首次因感染住院、死亡、14 岁生日、移民或 2009 年底。暴露是指母亲在怀孕期间和怀孕期间开具的抗生素。结果是与感染相关的住院治疗。
141359 名(18%)母亲在怀孕期间至少开了一种抗生素处方,230886 名(完整数据的 29.4%)在怀孕前 18 个月内开了处方。在 776657 名活产单胎婴儿中,有 443546 例(28.6%)儿童因感染相关而住院。妊娠期间使用抗生素与儿童感染相关住院风险增加相关(风险比[HR]1.18,95%置信区间[CI]1.17-1.19)。在仅在怀孕期间开具抗生素处方且其子女未接受住院前抗生素治疗的母亲中,这种关联仅存在于阴道分娩的婴儿中。当妊娠抗生素处方更接近分娩时,以及母亲接受更多妊娠抗生素时,感染相关住院的风险更高。在母亲妊娠前(但不是怀孕期间)暴露于抗生素的儿童中,感染相关住院的风险也增加(HR 1.10,95%CI 1.07-1.12)。
在怀孕前后接触抗生素与儿童住院感染风险增加有关。母体衍生微生物组的改变以及可共享的遗传和环境决定因素可能是促成机制。